PMVP
Pmv Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$67.20M
P/E Ratio
—
EPS
$-1.48
Beta
1.41
52W High
$1.88
52W Low
$0.85
50-Day MA
$1.38
200-Day MA
$1.34
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Pmv Pharmaceuticals Inc
PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53 mutations in cancer. The company is headquartered in Cranbury, New Jersey.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-83.53M |
| Operating Margin | 0.00% |
| Return on Equity | -63.20% |
| Return on Assets | -39.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.96 |
| Price-to-Book | 0.76 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $53.33M |
| Float | $43.14M |
| % Insiders | 3.35% |
| % Institutions | 69.52% |
Historical Volatility
HV 10-Day
63.62%
HV 20-Day
51.13%
HV 30-Day
54.37%
HV 60-Day
74.12%
HV Rank
24.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.33 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026